January 2025

Professionals having proven competency and success in their area of specialization, with at least 10 years of post- qualification experience and should possess minimum M.Sc, B.Tech, BE, MCA, MPH, B.Pharm, BSMS, MD in AYUSH.

First Class M.Pharm, M.S. Pharm in Pharmaceutical Chemistry, Pharmaceutical Analysis, Medicinal Chemistry. Ability to design and execute independent research studies. Working knowledge of bioinformatic tools for the development of new synthetic compounds. Development of New Quinoxaline based 2-Pyrazolines as Potent and Selective MAO-A Inhibitors, In silico Studies, Synthesis and Biological Evaluation

First Class Post Graduate Degree, including the integrated PG degrees, with three years of experience or PhD in the field of life science, biology, genomics, genetics, bioinformatics or related . Second Class Post Graduate Degree, including the integrated PG degrees with PhD and three years of experience in the field of life science, biology, genomics, genetics, bioinformatics or related

B.Pharmacy from recognized Institute, 10 plus 2 with science stream from recognized board, Approved diploma in Pharmacy.

B.Pharmacy from a recognized institute or 10+2 with science stream Physics, Chemistry. Biology Approved Diploma In Pharmacy from an institute recognized by the Pharmacy council of India and registered as Pharmacist under Pharmacist Act 1948.

B.Pharm with minimum 01-year experience of working in Dispensary, Pharmacy of any recognized hospital OR D.Pharm with minimum 3 years of experience of working in a Dispensary, Pharmacy of any recognized hospital. 

Operation and Calibration of HPLC Waters and SHIMADZU, GC, UV, FTIR, K, F, MS, IC and other instruments, Instrument Qualification knowledge required. Analysis of Raw material and Excipients and handling of HPLC Waters and SHIMADZU, GC Agilent, UV, FTIR, K/F, AAS, 1C and other instruments

Cardio Diabetic, Vascular, Acute, Antibiotics, Anti Hypertension & Respiratory. Macleods Pharmaceuticals Ltd. is one of the fastest growing pharmaceutical company.

Researchers at The University of Hong Kong have made an exciting discovery about how human cells protect DNA during cell division, offering new insights into combating diseases such as cancer. Led by Professor Gary Ying Wai CHAN from the School of Biological Sciences, Faculty of Science, and Professor Ken Hoi Tang MA from the Department of Pathology, LKS Faculty of Medicine, the research uncovers the vital role of a protein called PICH in preventing genetic errors that can lead to diseases such as cancer. Their findings were recently published in the journal Nucleic Acids Research.